Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: A single-center observational cohort study

Clinical Infectious Diseases

Volumn 39, Issue 11, 2004, Pages 1625-1632

  Jaffe, Dana ^a   Jakubowski, Ann ^a   Sepkowitz, Kent ^a   Sebti, R ^a,b   Kiehn, Timothy E ^a   Pamer, Eric ^a   Papanicolaou, Genovefa A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTEREMIA; CHILD; CHRONIC MYELOID LEUKEMIA; DOSE RESPONSE; FEMALE; GENDER; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; RISK FACTOR; VIRIDANS STREPTOCOCCAL BACTEREMIA; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MIDDLE AGED; RISK FACTORS; STREPTOCOCCAL INFECTIONS; TIME FACTORS; VANCOMYCIN; VIRIDANS STREPTOCOCCI;

EID: 9644260655     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/425612     Document Type: Article

References (34)

1. Elting LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis 1992; 14:1201-7.
2. Bochud PY, Eggiman P, Calandra T, Van Melle G, Saghafi L, Francioli P. Bacteremia due to viridans S treptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis 1994; 18:25-31.
3. Shenep JL. Viridans-group streptococcal infections in immunocompromised hosts. Int J Antimicrob Agents 2000; 14:129-35.
4. Bilgrami S, Feingold JM, Dorsky D, Edwards RL, Clive J, Tutschka PJ. Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1998;21:591-5.
5. Villablanca JG, Steiner M, Kersey J, et al. The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients. Bone Marrow Transplant 1990; 5:387-93.
6. Marron A, Carratala J, Gonzalez-Barca E, Fernandez-Sevilla A, Alcaide F, Gudiol F. Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer. Clin Infect Dis 2000; 31:1126-30.
7. Martino R, Subira M, Manteiga R, et al. Viridans streptococcal bacteremia and viridans streptococcal shock syndrome in neutropenic patients: comparison between children and adults receiving chemotherapy of chemotherapy or undergoing bone marrow transplantation. Clin Infect Dis 1995; 20:476-7.
8. Ruescher TJ, Sodeifi A, Scrivani SJ, Kaban LB, Sonis ST. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 1998;82:2275-81.
9. Razonable RR, Litzow MR, Khaliq Y, Piper KE, Rouse MS, Patel R. Bacteremia due to viridans group streptococci with diminished susceptibility to levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. Clin Infect Dis 2002; 34:1469-74.
10. Arns da Cunha C, Weisdorf D, Shu XO, DeFor T, Pastor JD III, Johnson JR. Early gram-positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis. Bone Marrow Transplant 1998; 21:173-80.
11. Attal M, Schlaifer D, Rubie H, et al. Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial. J Clin Oncol 1991; 9:865-70.
12. Feld R. Vancomycin as part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancer: pros and cons. Clin Infect Dis 1999; 29:503-7.
13. Koc Y, Snydman DR, Schenkein DS, Miller KB. Vancomycin-resistant enterococcal infections in bone marrow transplant recipients. Bone Marrow Transplant 1998; 22:207-9.
14. Kirkpatrick BD, Harrington SM, Smith D, et al. An outbreak of vancomycin-dependent Enterococcus faecium in a bone marrow transplant unit. Clin Infect Dis 1999; 29:1268-73.
15. Meier E AN, Jaffe D, Small T, Sepkowitz K, Papanicolaou G. Fever after allogeneic HSCT: correlation with infection, engraftment, and outcome [abstract 332]. In: Program and abstracts of the 41st Annual Meeting of the Infectious Diseases Society of America (Chicago). Alexandria, VA: Infectious Diseases Society of America, 2003.
16. Eilers J, Berger AM, Petersen MC. Development, testing, and application of the oral assessment guide. Oncol Nurs Forum 1988; 15:325-30.
17. Stata statistical software: release 7 [program]. College Station, TX: Stata, 2000.
18. NCCLS. Performance standards for antimicrobial susceptibility testing: 8th informational supplement. NCCLS document M100-S12. Wayne, PA: NCCLS, 2002.
19. Tunkel AR, Sepkowitz KA. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis 2002; 34:1524-9.
20. Steiner M, Villablanca J, Kersey J, et al. Viridans streptococcal shock in bone marrow transplantation patients. Am J Hematol 1993; 42:354-8.
21. Bostrom B, Weisdorf D. Mucositis and alpha-streptococcal sepsis in bone marrow transplant recipients. Lancet 1984; 1:1120-1.
22. Ringden O, Heimdahl A, Lonnqvist B, Malmborg AS, Wilczek H. Decreased incidence of viridans streptococcal septicaemia in allogeneic bone marrow transplant recipients after the introduction of acyclovir. Lancet 1984; 1:744.
23. Anaissie EJ, Kontoyiannis DP, O'Brien S, et al. Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med 1998; 129:559-66.
24. Engelhard D, Elishoov H, Or R, et al. Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective study. Bone Marrow Transplant 1995; 16:565-70.
25. Sotiropoulos SV, Jackson MA, Woods GM, Hicks RA, Cullen J, Freeman AI. Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside. Pediatr Infect Dis J 1989;8:755-8.
26. Valteau D, Hartmann O, Brugieres L, et al. Streptococcal septicaemia following autologous bone marrow transplantation in children treated with high-dose chemotherapy. Bone Marrow Transplant 1991; 7:415-9.
27. Shenep JL, Hughes WT, Roberson PK, et al. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. N Engl J Med 1988; 319:1053-8.
28. Cometta A, Kern WV, De Bock R, et al. Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy. Clin Infect Dis 2003; 37:382-9.
29. Schots R, Trullemans F, Van Riet I, et al. The clinical impact of early gram-positive bacteremia and the use of vancomycin after allogeneic bone marrow transplantation. Transplantation 2000; 69:1511-4.
30. Broun ER, Wheat JL, Kneebone PH, Sundblad K, Hromas RA, Tricot G. Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation. Antimicrob Agents Chemother 1994; 38:576-9.
31. Maraninchi D, Hartman O, Benhamou E, et al. Prophylaxis of gram-positive infections after bone marrow graft: controlled study of the 6-day administration of vancomycin. Intermediate analysis of 60 patients [in French]. Pathol Biol (Paris) 1988; 36:915-9.
32. Ford CD, Reilly W, Wood J, Classen DC, Burke JP. Oral antimicrobial prophylaxis in bone marrow transplant recipients: randomized trial of ciprofloxacin versus ciprofloxacin-vancomycin. Antimicrob Agents Chemother 1998; 42:1402-5.
33. Teinturier C, Hartmann O, Lemerle J, Benhamou E, Maraninchi D. Prevention of gram-positive infections in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomized controlled trial of vancomycin. Pediatr Hematol Oncol 1995; 12:73-7.
34. Small TN, Boulad F, Papadopoulos E, et al. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following allogeneic hematopoietic stem cell transplant (HSCT). In: Program and abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 2002:325.